They will consider new warning labels about increased risk of blood clots linked to contraceptivesDecember 8, 2011
By Steven Reinberg
THURSDAY, Dec. 8 (HealthDay News) -- Two U.S. Food and Drug Administration advisory panels will meet Thursday to discuss whether to recommend new warning labels about increased risk of blood clots with newer forms of oral contraceptives.
The Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee will hear from experts and the public, and then make a recommendation to the full FDA. The agency typically follows the advice of its advisory panels.
FDA Panels to Weigh Safety of Newer Forms of the 'Pill' - US News and World Report